1. Home
  2. BON vs LEXX Comparison

BON vs LEXX Comparison

Compare BON & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bon Natural Life Limited

BON

Bon Natural Life Limited

N/A

Current Price

$1.22

Market Cap

8.7M

Sector

Health Care

ML Signal

N/A

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

N/A

Current Price

$3.23

Market Cap

8.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BON
LEXX
Founded
2006
2004
Country
China
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
8.7M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
BON
LEXX
Price
$1.22
$3.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $1.50
AVG Volume (30 Days)
7.0K
★ 102.2K
Earning Date
01-23-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $705,923.00
Revenue This Year
$390.73
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 52.05
52 Week Low
$0.98
$0.35
52 Week High
$2.34
$14.37

Technical Indicators

Market Signals
Indicator
BON
LEXX
Relative Strength Index (RSI) 57.73 36.66
Support Level $1.14 $0.57
Resistance Level $1.22 $12.89
Average True Range (ATR) 0.06 1.01
MACD 0.01 -0.34
Stochastic Oscillator 87.82 8.56

Price Performance

Historical Comparison
BON
LEXX

About BON Bon Natural Life Limited

Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: